Table 4.
Analysis of the association between CD30 expression and clinicopathological parameters of the 41 DLBCL NOS cases
| Variables | CD30 positive | CD30 negative | p-value |
|---|---|---|---|
|
Sex Female Male |
2 2 |
19 18 |
1.00 |
|
Age (mean age: 61,95 years) < 60 ≥ 60 |
3 1 |
13 24 |
0.28 |
|
Site Oral cavity Oropharynx |
3 1 |
28 9 |
1.00 |
|
Status Alive Dead |
3 1 |
7 13 |
0.27 |
|
CD10 expression Positive Negative |
0 4 |
13 24 |
0.28 |
|
MUM1 expression Positive Negative |
3 1 |
27 10 |
1.00 |
|
Bcl2 expression Positive Negative |
3 1 |
26 11 |
1.00 |
|
Bcl6 expression Positive Negative |
3 1 |
26 10 |
1.000 |
|
c-Myc expression Positive Negative |
2 2 |
12 24 |
0.60 |
|
Ki67 index < 56.2% ≥ 56.2% |
2 2 |
19 17 |
1.00 |
|
Hans algorithm GCB Non-GCB |
1 3 |
19 18 |
0.60 |
|
BCL2 translocation Positive Negative |
1 2 |
3 26 |
0.34 |
|
BCL6 translocation Positive Negative |
0 3 |
0 29 |
NA |
|
MYC translocation Positive Negative |
0 3 |
3 26 |
1.000 |
GCB: Germinal centre B-cell type; Non-GBC: Non-germinal center B cell type. NA: not applied